In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Intuitive Surgical (ISRG). The company’s shares closed last Thursday at $510.44.
According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of 10.6% and a 63.9% success rate. Biegelsen covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Inspire Medical Systems, and Zimmer Biomet Holdings.
Intuitive Surgical has an analyst consensus of Moderate Buy, with a price target consensus of $568.82, a 10.5% upside from current levels. In a report issued on April 8, Piper Sandler also reiterated a Buy rating on the stock with a $633.00 price target.
See today’s analyst top recommended stocks >>
Intuitive Surgical’s market cap is currently $59.59B and has a P/E ratio of 44.30. The company has a Price to Book ratio of 7.61.
Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ISRG in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Read More on ISRG:
